Ishii, Hidenobu
Azuma, Koichi
Kawahara, Akihiko
Matsuo, Norikazu
Tokito, Takaaki
Hoshino, Tomoaki
Funding for this research was provided by:
Japan Society for the Promotion of Science (19K16814)
Article History
Received: 18 July 2020
Accepted: 4 August 2020
First Online: 11 August 2020
Compliance with ethical standards
:
: Dr. Ishii reports grants and personal fees from Boerhinger-Ingelheim, personal fees from Ono Pharmaceutical, personal fees from Chugai Pharmaceutical, personal fees from Astra Zeneca, outside the submitted work. Dr. Azuma reports personal fees from AstraZeneca, grants and personal fees from Boehringer Ingelheim, grants and personal fees from Ono Pharmaceutical, grants and personal fees from MSD Oncology, grants and personal fees from Bristol-Myers Squibb, grants and personal fees from Chugai Pharma, outside the submitted work. Dr. Kawahara has nothing to disclose. Dr. Matsuo reports personal fees from Boerhinger-Ingelheim, personal fees from Chugai Pharmaceutical, outside the submitted work. Dr. Tokito reports personal fees from Ono Pharmaceutical, personal fees from MSD Oncology, personal fees from Chugai Pharmaceutical, personal fees from Astra Zeneca, outside the submitted work. Dr. Hoshino reports grants from GSK Japan, grants from Novartis Pharmaceuticals Japan, grants from Chugai Pharmaceutical Co. Ltd., outside the submitted work.
: All procedures performed in studies involving human participants were in accordance with the declaration of Helsinki and ethical standards of the institutional research committee.
: Patient samples (anonymized) were taken as part of routine clinical care.
: Patient samples (anonymized) were taken as part of routine clinical care.